Insulet Corporation (PODD) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

23/25

Growth 4 Margin 5 Expansion 5 Platform 4 Financial 5

latest quarter score

Earnings Reports

23
Insulet (PODD) Q2 2026: Type 2 Retention Challenge Drives Guidance Reset Despite 23% Global Growth
August 05, 2026
22
PODD Q1 2026: International Revenue Jumps 45% as Omnipod 5 Drives Global Penetration
May 06, 2026
21
PODD Q4 2025: Omnipod Drives 29% Revenue Growth as Type 2 Penetration Accelerates
February 24, 2026
25
PODD Q3 2025: International Omnipod Revenue Jumps 40%, Accelerating Global Penetration
November 06, 2025
25
PODD Q2 2025: International Omnipod 5 Adoption Hits 50%, Driving Durable Margin Expansion
August 07, 2025
24
Insulet (PODD) Q1 2025: Omnipod 5 Drives 30% Revenue Growth as Type 2 Adoption Rises
July 05, 2025

Browse all companies